[Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Modulation of a number of protooncogene expression occurs during differentiation of eukaryotes. Changes in expression of c-myb and c-myc during the HMBA-induced terminal differentiation of murine erythroleukemia cells were characterized by an early decrease (within 4 hrs), followed by the recovery of c-myc mRNA by 10 hrs, and the retention of suppression of c-myb expression for the rest of the induction period. Two MELC variants were used to further define the relationship between the differentiation and the protooncogene expression. R1 was a MELC variant completely resistant to HMBA, and R1 (VCR), a vincristine resistant R1, became inducible by HMBA again. The cell differentiation and the c-myb and c-myc expression were determined on R1 or R1 (VCR) cultured with HMBA respectively. The results demonstrated that the c-myc mRNA increased and remained relatively high as the cells grew to a saturated density regardless of the induction of differentiation. The R1 (VCR) cultured with HMBA displayed an early decrease in c-myb mRNA and a subsequent suppression of its expression, while the R1 cultured with HMBA showed a stable level of c-myb mRNA. These results suggest that the c-myb expression, rather than c-myc expression, is closely related to the HMBA-induced terminal differentiation.